bf/NASDAQ:BNTX_icon.jpeg

NASDAQ:BNTX

BioNTech SE

  • Stock

$

USD

Last Close

129.39

23/03 20:01

Market Cap

31.11B

Beta: 0.20

Volume Today

836.9K

Avg: 892.2K

PE Ratio

3.32

PEG: 0.00

Dividend Yield

2.22%

Payout:6.19%

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Select
  • website

    www.biontech.de
  • ipo date

    Oct 10, 2019
  • full time employees

    4,000
  • currency

    USD

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to ...Show More

Earnings per Share (Estimate)

510152019-11-142020-07-022020-11-102021-08-092022-03-302022-08-082023-03-27

Revenue (Estimate)

1B2B3B4B5B6B2019-11-142020-07-022020-11-102021-08-092022-03-302022-08-082023-03-27